Skip to main content
Clinical Trials/NCT03419182
NCT03419182
Completed
N/A

Randomized Controlled Trial to Determine the Best Treatment of Acetabular Fractures in Geriatric Patients: Open Reduction Internal Fixation With or Without Primary Total Hip Arthroplasty

University of Maryland, Baltimore1 site in 1 country53 target enrollmentApril 13, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acetabular Fracture
Sponsor
University of Maryland, Baltimore
Enrollment
53
Locations
1
Primary Endpoint
The primary outcome measure for this study is the proportion of complications in the first 12 months following surgery
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

There is debate over the best management for acetabular (hip) fractures that occur within the geriatric population. Geriatric patients, 60 years or older, are at greater risk for operative complications because they tend to have poorer bone quality, complicated fractures, and multiple health problems. Physicians currently have no guidelines as to the best surgical management for these particular fractures, because there is little data on the long-term outcomes of these injuries. The use of internal fixation (a nail or plate) is a standard method for repairing these injuries, however when the injuries are complicated it is predicted to have a poorer outcome than performing internal fixation along with total hip arthroplasty (joint reconstruction). Given the significant problems that result from hip fractures in this population, our study is designed to determine the best method for treatment of acetabular fractures and to clarify the criteria for treatment with guidelines assisting the physician in selecting the appropriate treatment.

Detailed Description

This is a pilot randomized controlled study conducted at Shock Trauma and University of Maryland Medical Center of patients 60 years and older who have sustained an acetabular fracture. Based on the patient's fracture pattern, dome impaction, posterior wall component and femoral head fracture, the patients will be randomized to their treatment arm. One treatment arm will consist of patients who are treated with ORIF alone. The other treatment will undergo ORIF as well as concomitant total hip arthroplasty in the same surgery. Furthermore the functional status evaluation of each patient will be standardized using the WOMAC (Western Ontario McMaster Universities OA index), a lower extremity specific outcome score that has been validated for use in patients of similar age to our cohort study in osteoarthritis or after total hip arthroplasty; and the SF-36 (Short Form-36) which is a validated general health outcome measure that calculates mental and physical subcomponent scores. Patients will also be assessed using the Harris Hip Score, which has been used for patients with post-traumatic arthritis undergoing conversion to total hip arthroplasty. All patients will be followed as standard of care for their follow up visits at 6 month and 1 year. As the patient population at Shock Trauma and University of Maryland Medical Center are all treated by the same orthopaedic group, one dedicated investigator will follow their outcomes. To minimize the risk of bias, I, the individual administering the WOMAC or SF-36 will be blinded to the patient's treatment arm. As the patient will be giving consent for their treatment, they cannot be blinded. Also, the surgeons (and the research coordinator) will know which group the patient is in, but the investigator collecting the data will not.

Registry
clinicaltrials.gov
Start Date
April 13, 2011
End Date
April 1, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Theodore Manson

Associate Professor

University of Maryland, Baltimore

Eligibility Criteria

Inclusion Criteria

  • Patients 60 years and older at the time of injury who have sustained an acetabular fracture
  • Fluent in the English Language

Exclusion Criteria

  • Patients under the Age of 60 years old
  • Patients who are medically contraindicated for surgery
  • Patients who in the surgeon's view will be unable to comply with posterior hip precautions (to prevent dislocation) after surgery
  • In patients with bilateral acetabular fractures, the most severe side will be randomized into the study while the other side will be treated but not included in the study.
  • Open Injuries

Outcomes

Primary Outcomes

The primary outcome measure for this study is the proportion of complications in the first 12 months following surgery

Time Frame: 1 year

Researchers will assess treatment success using a two-group comparison of proportion of complications between the treatment groups during the first 12 months following treatment. Complications will be identified by radiographic and clinical evaluation during standard follow-up appointments with the treating surgeon. Complications include postoperative infections, non-union, mal-union, development of heterotopic bone, development of osteoarthritis, osteolysis, hardware failure, hip dislocations, surgical revisions, and any other condition related to surgical treatment of the study injury.

Secondary Outcomes

  • A secondary outcome for this study is to evaluate patient reported outcomes using the WOMAC Questionnaire.(6 months and 12 months)
  • A secondary outcome for this study is to evaluate patient reported outcomes using the SF36 Questionnaire.(6 months and 12 months)

Study Sites (1)

Loading locations...

Similar Trials